Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.13434 http://scihub22266oqcxt.onion/10.1111/dth.13434 32314483!7235531!32314483     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dermatol+Ther 2020 ; 33 (4): e13434 Nephropedia Template TP {{tp|p=32314483|t=2020. COVID-19 and psoriasis: Should we fear for patients treated with biologics?|pdf=|usr=}}{{32314483}} gab.com Text COVID-19 and psoriasis: Should we fear for patients treated with biologics JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32314483 #FOAvip The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. Twit Text FOAVip COVID-19 and psoriasis: Should we fear for patients treated with biologics ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32314483 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32314483 #FOAvip English Wikipedia <ref>{{Cite pmid|32314483}}</ref> COVID-19 and psoriasis: Should we fear for patients treated with biologics? #MMPMID32314483 Amerio P; Prignano F; Giuliani F; Gualdi G Dermatol Ther 2020[Jul]; 33 (4): e13434 PMID32314483show ga The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Humans[MESH] |Immunologic Factors/*administration & dosage/adverse effects[MESH] |Immunosuppressive Agents/administration & dosage/adverse effects[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology[MESH]COVID-19 and psoriasis: Should we fear for patients treated with biolo(epmc).pdf DeepDyve Pubget Overpricing